Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach

[1]  F. Scheperjans.  Can microbiota research change our understanding of neurodegenerative diseases? , 2016, Neurodegenerative disease management.

[2]  Anumantha Kanthasamy,et al.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. , 2016, Pharmacology & therapeutics.

[3]  A. Camins,et al.  The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. , 2015, Life sciences.

[4]  K. Gomes,et al.  Leptin in Alzheimer's disease. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[5]  R. Catanzaro,et al.  The gut microbiota and its correlations with the central nervous system disorders. , 2015, Panminerva medica.

[6]  T. Sakurai,et al.  Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease , 2015, Experimental Neurology.

[7]  J. Clarimón,et al.  Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease , 2015, Neurology.

[8]  M. Mandler,et al.  Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease , 2015, Journal of Neuroinflammation.

[9]  P. S. St George-Hyslop,et al.  ATP-binding Cassette Transporter A7 (ABCA7) Loss of Function Alters Alzheimer Amyloid Processing* , 2015, The Journal of Biological Chemistry.

[10]  Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease , 2015, Journal of Neuroinflammation.

[11]  Seung-Chul Hong,et al.  Sleep and Alzheimer’s Disease , 2015 .

[12]  G. Pasinetti,et al.  Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization. , 2015, Molecular nutrition & food research.

[13]  M. Bastin,et al.  Memory binding and white matter integrity in familial Alzheimer's disease. , 2015, Brain : a journal of neurology.

[14]  Joanne Wuu,et al.  Resilience of Precuneus Neurotrophic Signaling Pathways Despite Amyloid Pathology in Prodromal Alzheimer’s Disease , 2015, Biological Psychiatry.

[15]  I. Bezprozvanny,et al.  Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease. , 2015, Seminars in cell & developmental biology.

[16]  Behzad Khallaghi,et al.  Impairment of Rat Spatial Learning and Memory in a New Model of Cold Water-Induced Chronic Hypothermia: Implication for Alzheimer’s Disease , 2015, Neurotoxicity Research.

[17]  Margarida Silveira,et al.  Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages , 2015, Comput. Biol. Medicine.

[18]  M. Heneka,et al.  Innate immunity in Alzheimer's disease , 2015, Nature Immunology.

[19]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[20]  T. Hökfelt,et al.  Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease , 2015, Acta Neuropathologica.

[21]  R. D'Hooge,et al.  Rescue of impaired late–phase long-term depression in a tau transgenic mouse model , 2015, Neurobiology of Aging.

[22]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[23]  C. Bethea,et al.  Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques , 2015, Molecular Psychiatry.

[24]  F. LaFerla,et al.  Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss , 2015, Hippocampus.

[25]  Chieko Suzuki,et al.  Changes in daily cognition and behavior of Alzheimer’s patients over time: A three-year evaluation using a daily cognition and behavior for Alzheimer’s disease scale , 2015, Dementia.

[26]  M. Baumann,et al.  Notch signaling and ageing. , 2015, Advances in experimental medicine and biology.

[27]  M. Rantalainen,et al.  An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients. , 2015, Journal of Alzheimer's disease : JAD.

[28]  Li Wang,et al.  Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats , 2014, Neuroscience Bulletin.

[29]  D. G. Clark,et al.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. , 2014, JAMA neurology.

[30]  Y. Li,et al.  Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. , 2014, European journal of pharmacology.

[31]  P. Roos.  Osteoporosis in neurodegeneration. , 2014, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[32]  G. Casadesus,et al.  Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[33]  R. Tanzi,et al.  Rare autosomal copy number variations in early-onset familial Alzheimer’s disease , 2014, Molecular Psychiatry.

[34]  S. M. de la Monte,et al.  Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.

[35]  R. Mayeux,et al.  Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers , 2014 .

[36]  Yang Yang,et al.  Integrating Gene Expression and Protein Interaction Data for Signaling Pathway Prediction of Alzheimer's Disease , 2014, Comput. Math. Methods Medicine.

[37]  Mohammad A Kamal,et al.  A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update. , 2014, CNS & neurological disorders drug targets.

[38]  Joaquín Dopazo,et al.  Pathway network inference from gene expression data , 2014, BMC Systems Biology.

[39]  B. Hooshmand,et al.  Advances in the prevention of Alzheimer's disease and dementia , 2014, Journal of internal medicine.

[40]  I. Santana,et al.  Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines , 2014, Metabolic Brain Disease.

[41]  Jack Hunt,et al.  F-box Only Protein 2 (Fbxo2) Regulates Amyloid Precursor Protein Levels and Processing* , 2014, The Journal of Biological Chemistry.

[42]  B. de Strooper,et al.  Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling , 2014, PloS one.

[43]  Fuhai Song,et al.  AlzBase: an Integrative Database for Gene Dysregulation in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[44]  M. Matsuoka.  Protective Effects of Humanin and Calmodulin-Like Skin Protein in Alzheimer’s Disease and Broad Range of Abnormalities , 2014, Molecular Neurobiology.

[45]  Paul M. Thompson,et al.  Neuroimaging and genetic risk for Alzheimer’s disease and addiction-related degenerative brain disorders , 2013, Brain Imaging and Behavior.

[46]  Alzheimer’s as a metabolic disease , 2013, Biogerontology.

[47]  Tanya Z. Berardini,et al.  The Gene Ontology (GO) Cellular Component Ontology: integration with SAO (Subcellular Anatomy Ontology) and other recent developments , 2013, J. Biomed. Semant..

[48]  The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease , 2013, Acta neuropathologica communications.

[49]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[50]  Cristina Marino Buslje,et al.  Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid β (Aβ) Peptide Catabolism and Functionality* , 2013, The Journal of Biological Chemistry.

[51]  A. Cattaneo,et al.  Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation , 2013, Biochemical and biophysical research communications.

[52]  J. Satoh,et al.  Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains , 2013, Neuropathology and applied neurobiology.

[53]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[54]  O. Forlenza,et al.  Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease , 2012, NeuroMolecular Medicine.

[55]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[56]  Margaret A. Pericak-Vance,et al.  Novel late-onset Alzheimer disease loci variants associate with brain gene expression , 2012, Neurology.

[57]  Marc Cruts,et al.  Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.

[58]  Thomas E. Nichols,et al.  Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease , 2012, Neurobiology of Aging.

[59]  Zhongming Zhao,et al.  GenRev: exploring functional relevance of genes in molecular networks. , 2012, Genomics.

[60]  Jianmin Wu,et al.  PINA v2.0: mining interactome modules , 2011, Nucleic Acids Res..

[61]  C. Caltagirone,et al.  Impaired LTP- but not LTD-like cortical plasticity in Alzheimer's disease patients. , 2012, Journal of Alzheimer's disease : JAD.

[62]  Peilin Jia,et al.  A comprehensive network and pathway analysis of candidate genes in major depressive disorder , 2011, BMC Systems Biology.

[63]  T. Goldberg,et al.  Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype , 2011, Molecular Psychiatry.

[64]  M. Sabbagh,et al.  Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease , 2011, Acta Neuropathologica.

[65]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[66]  G. Terstappen,et al.  VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[68]  A. Copani,et al.  Alzheimer's disease: brain expression of a metabolic disorder? , 2010, Trends in Endocrinology & Metabolism.

[69]  Jason H. Moore,et al.  Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans , 2010, Alzheimer's & Dementia.

[70]  N. Ertekin-Taner.  Genetics of Alzheimer disease in the pre- and post-GWAS era , 2010, Alzheimer's Research & Therapy.

[71]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[72]  K. Anstey,et al.  Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[73]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[74]  B. Palmer,et al.  Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. , 2009, Arthritis and rheumatism.

[75]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[76]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[77]  A. Barabasi,et al.  A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.

[78]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[79]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[80]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[81]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[82]  R. Ravi,et al.  A nearly best-possible approximation algorithm for node-weighted Steiner trees , 1993, IPCO.

[83]  B. Bollobás.  The evolution of random graphs , 1984 .

[84]  P. Erdos,et al.  On the evolution of random graphs , 1984 .